TWO SIGMA ADVISERS, LP - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$13,000
-90.1%
49,300
-78.9%
0.00%
Q1 2022$131,000
-60.4%
233,400
-50.1%
0.00%
-100.0%
Q4 2021$331,000
-71.2%
468,000
-33.6%
0.00%
-66.7%
Q3 2021$1,150,000
+157.3%
705,300
+214.2%
0.00%
+200.0%
Q2 2021$447,000224,5000.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,930,092$1,363,0000.55%
AMERICAN FINANCIAL GROUP INC 1,480,000$1,045,0000.29%
Vanguard Capital Wealth Advisors 158,900$111,0000.08%
Anson Funds Management LP 553,652$391,0000.04%
Nantahala Capital Management 894,659$632,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,479,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$831,0000.02%
Atom Investors LP 113,151$80,0000.01%
Virtu Financial LLC 130,270$91,0000.01%
Altshuler Shaham Ltd 1,157,540$828,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders